HESI Mental Health Exam Prep Document | 2026/2027
Edition | 250 Verified Questions
HESI Mental Health Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED
A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document features 250 verified questions and answers with
rationales for the HESI Mental Health exam. Designed to reflect the latest 2026/2027 guidelines, it
covers key psychiatric nursing concepts including therapeutic communication, psychopharmacology,
and crisis intervention. Each question is accompanied by detailed rationales to reinforce learning and
clinical reasoning. Ideal for nursing students seeking a thorough review and successful exam outcome.
Key Features:
Therapeutic Communication and the Nurse-Patient Relationship
Psychopharmacology and Medication Management
Crisis Intervention and Suicide Prevention
Mood Disorders, Anxiety, and Psychotic Disorders
Personality Disorders and Eating Disorders
Legal and Ethical Issues in Mental Health Nursing
Updates for 2026:
- Updated to reflect 2026/2027 HESI exam blueprint changes
- Incorporated latest DSM-5-TR diagnostic criteria
- Revised rationales to include current evidence-based practices
- Added new questions on telehealth and COVID-19 mental health impacts
- Enhanced distractor explanations to clarify common misconceptions
Abstract:
This document provides a rigorous review of mental health nursing concepts essential for the HESI exam. It
encompasses 250 carefully selected questions that test knowledge across major psychiatric disorders, therapeutic
interventions, and professional standards. Each question includes a correct answer with a detailed rationale
explaining the underlying principle, as well as analysis of incorrect options to deepen understanding. The content
is aligned with the 2026/2027 academic year and incorporates the latest DSM-5-TR criteria and evidence-based
practices. Emphasis is placed on critical thinking and application to clinical scenarios, preparing students for both
the exam and real-world psychiatric nursing. This resource is ideal for self-assessment and targeted study,
ensuring comprehensive coverage of high-yield topics. The structured format facilitates efficient review and
retention of key information.
Keywords:
HESI Mental Health, psychiatric nursing, exam prep, 250 questions, rationales, 2026/2027, DSM-5-TR,
therapeutic communication
Answer Format:
Each question is presented with four answer options, followed by the correct answer and a comprehensive
rationale. The rationale explains why the correct answer is right and why each distractor is incorrect, often
referencing nursing principles, drug mechanisms, or diagnostic criteria. This format promotes deep understanding
and clinical reasoning.
Compliance Checklist:
All questions verified against 2026/2027 HESI exam guidelines
Rationales cite current evidence-based sources and DSM-5-TR
Page 1
, Content covers all major mental health nursing domains
Distractors designed to reflect common student errors
Format mirrors actual HESI exam question style
Content Area Overview:
Content Area Questions Key Topics Weight
Therapeutic Communication & 1-40 active listening, empathy, boundaries, 16%
Nurse-Patient Relationship transference, countertransference
Psychopharmacology 41-80 antidepressants, antipsychotics, mood 16%
stabilizers, anxiolytics, side effects
Crisis Intervention & Suicide 81-110 crisis phases, suicide assessment, safety 12%
Prevention planning, de-escalation
Mood Disorders & Anxiety 111-150 major depression, bipolar disorder, GAD, 16%
panic disorder, PTSD
Psychotic Disorders 151-180 schizophrenia, delusions, hallucinations, 12%
negative symptoms
Personality & Eating Disorders 181-210 borderline, antisocial, anorexia, bulimia, 12%
nursing interventions
Legal & Ethical Issues 211-250 informed consent, confidentiality, 16%
involuntary commitment, HIPAA
Page 2
,Q1. A client with a history of opioid use disorder is admitted for elective surgery. The client has been
maintained on buprenorphine/naloxone for the past 6 months. Which of the following actions by the nurse is
most appropriate regarding the client's buprenorphine/naloxone regimen during the perioperative period?
A. Discontinue buprenorphine/naloxone 72 hours prior to surgery and initiate full agonist opioids for pain
management.
B. Continue buprenorphine/naloxone at the same dose and use non-opioid analgesics and regional anesthesia
for pain control.
C. Increase the dose of buprenorphine/naloxone to compensate for anticipated surgical pain.
D. Switch to methadone for the perioperative period to allow for easier titration of additional opioids.
Correct Answer: B. Continue buprenorphine/naloxone at the same dose and use non-opioid analgesics and
regional anesthesia for pain control.
Rationale: Continuing buprenorphine/naloxone at the same dose is recommended to maintain stability and avoid
withdrawal. Non-opioid analgesics and regional anesthesia are preferred to manage pain without compromising
the buprenorphine's blockade. Discontinuation or dose changes risk relapse and inadequate pain control.
Why Wrong:
A - Discontinuing buprenorphine abruptly can precipitate withdrawal and increase risk of relapse; full
agonists may be less effective due to residual blockade.
C - Increasing buprenorphine dose does not enhance analgesia for acute surgical pain and may lead to
oversedation.
D - Switching to methadone requires careful cross-titration and is not standard perioperative management; it
complicates pain control.
Reference: SAMHSA. (2024). Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use
Disorder and Their Infants. HHS Publication No. (SMA) 24-4930.
Q2. A client with schizophrenia is started on clozapine after failing two previous antipsychotic trials. Which
of the following laboratory parameters requires the most urgent monitoring, and at what frequency is it
initially recommended?
A. Serum creatinine; weekly for the first 6 months.
B. Absolute neutrophil count (ANC); weekly for the first 18 weeks.
C. Liver function tests; monthly for the first year.
D. Electrocardiogram (ECG); at baseline and after each dose increase.
Correct Answer: B. Absolute neutrophil count (ANC); weekly for the first 18 weeks.
Rationale: Clozapine carries a risk of agranulocytosis, necessitating ANC monitoring weekly for the first 18 weeks
of treatment (then every 2 weeks for up to 1 year, then monthly). The other options are not the primary
life-threatening risk associated with clozapine.
Why Wrong:
A - Serum creatinine monitoring is not a required standard for clozapine; renal impairment is not a primary
concern.
C - Liver function tests are not routinely mandated for clozapine; hepatotoxicity is less common than
agranulocytosis.
D - ECG is recommended for some antipsychotics (e.g., ziprasidone) but is not the most urgent lab
monitoring for clozapine.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 16.
Q3. A client receiving electroconvulsive therapy (ECT) for severe major depressive disorder with psychotic
features is being prepared for a treatment session. Which of the following medication adjustments is most
critical to ensure safe and effective ECT?
A. Hold all benzodiazepines for at least 24 hours prior to treatment.
B. Administer a beta-blocker (e.g., esmolol) immediately before the procedure.
Page 3
, C. Discontinue all antidepressants 1 week before ECT initiation.
D. Increase the dose of antipsychotic medication to prevent breakthrough psychosis.
Correct Answer: A. Hold all benzodiazepines for at least 24 hours prior to treatment.
Rationale: Benzodiazepines raise the seizure threshold, reducing the effectiveness of ECT; they are typically held for 24-48
hours before treatment. Beta-blockers are sometimes used to control heart rate but are not mandatory. Antidepressants are
generally continued, and antipsychotics may be continued but not increased.
Why Wrong:
B - Beta-blockers are not a standard requirement; they are used selectively for hemodynamic control.
C - Discontinuing antidepressants is not recommended; they are often continued to maintain therapeutic effect.
D - Increasing antipsychotic dose is not standard; it may increase side effects without clear benefit.
Reference: American Psychiatric Association. (2024). Practice Guideline for the Treatment of Patients With Major Depressive
Disorder, 4th Ed.
Q4. A client with bipolar I disorder is stabilized on lithium carbonate. The client presents to the clinic with a
serum lithium level of 1.8 mEq/L and reports mild tremor, nausea, and blurred vision. Which of the following
interventions is most appropriate?
A. Administer a single dose of furosemide to enhance lithium excretion.
B. Hold the next dose and obtain a repeat serum level in 12 hours.
C. Increase fluid intake to 3-4 L per day and monitor symptoms.
D. Initiate hemodialysis immediately due to the risk of neurotoxicity.
Correct Answer: B. Hold the next dose and obtain a repeat serum level in 12 hours.
Rationale: A lithium level of 1.8 mEq/L is above the therapeutic range (0.6-1.2 mEq/L) and indicates toxicity.
Holding the next dose and rechecking the level is appropriate for mild toxicity. Furosemide can worsen toxicity by
decreasing lithium clearance. Hemodialysis is reserved for severe toxicity (levels >4 mEq/L or with severe
symptoms).
Why Wrong:
A - Furosemide is a loop diuretic that can cause volume depletion and increase lithium reabsorption,
worsening toxicity.
C - Increasing fluid intake may be helpful but is not sufficient; holding the dose is the priority.
D - Hemodialysis is indicated for severe toxicity; this level with mild symptoms does not warrant it.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 15.
Q5. A client with a diagnosis of borderline personality disorder frequently engages in self-harm behaviors,
specifically cutting. During a therapy session, the client states, 'I cut because it's the only way I can feel
something.' Which therapeutic response by the nurse is most consistent with dialectical behavior therapy
(DBT)?
A. I understand you feel that way, but cutting is dangerous. Let's discuss why you need to stop.
B. It sounds like you are experiencing intense emotions. What coping skills from your skills group could you
use instead?
C. You cut because you want attention. We need to find healthier ways to get your needs met.
D. I'm going to ask you to sign a no-harm contract for the next 24 hours.
Correct Answer: B. It sounds like you are experiencing intense emotions. What coping skills from your skills
group could you use instead?
Rationale: DBT emphasizes validation and skill-building. The nurse validates the client's experience and prompts
use of learned coping skills, which is core to DBT. Option A is invalidating; option C is judgmental; option D may
be used but is not the best therapeutic response in this context.
Why Wrong:
A - This response invalidates the client's emotion and focuses on stopping behavior without offering
alternatives.
Page 4
Edition | 250 Verified Questions
HESI Mental Health Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED
A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document features 250 verified questions and answers with
rationales for the HESI Mental Health exam. Designed to reflect the latest 2026/2027 guidelines, it
covers key psychiatric nursing concepts including therapeutic communication, psychopharmacology,
and crisis intervention. Each question is accompanied by detailed rationales to reinforce learning and
clinical reasoning. Ideal for nursing students seeking a thorough review and successful exam outcome.
Key Features:
Therapeutic Communication and the Nurse-Patient Relationship
Psychopharmacology and Medication Management
Crisis Intervention and Suicide Prevention
Mood Disorders, Anxiety, and Psychotic Disorders
Personality Disorders and Eating Disorders
Legal and Ethical Issues in Mental Health Nursing
Updates for 2026:
- Updated to reflect 2026/2027 HESI exam blueprint changes
- Incorporated latest DSM-5-TR diagnostic criteria
- Revised rationales to include current evidence-based practices
- Added new questions on telehealth and COVID-19 mental health impacts
- Enhanced distractor explanations to clarify common misconceptions
Abstract:
This document provides a rigorous review of mental health nursing concepts essential for the HESI exam. It
encompasses 250 carefully selected questions that test knowledge across major psychiatric disorders, therapeutic
interventions, and professional standards. Each question includes a correct answer with a detailed rationale
explaining the underlying principle, as well as analysis of incorrect options to deepen understanding. The content
is aligned with the 2026/2027 academic year and incorporates the latest DSM-5-TR criteria and evidence-based
practices. Emphasis is placed on critical thinking and application to clinical scenarios, preparing students for both
the exam and real-world psychiatric nursing. This resource is ideal for self-assessment and targeted study,
ensuring comprehensive coverage of high-yield topics. The structured format facilitates efficient review and
retention of key information.
Keywords:
HESI Mental Health, psychiatric nursing, exam prep, 250 questions, rationales, 2026/2027, DSM-5-TR,
therapeutic communication
Answer Format:
Each question is presented with four answer options, followed by the correct answer and a comprehensive
rationale. The rationale explains why the correct answer is right and why each distractor is incorrect, often
referencing nursing principles, drug mechanisms, or diagnostic criteria. This format promotes deep understanding
and clinical reasoning.
Compliance Checklist:
All questions verified against 2026/2027 HESI exam guidelines
Rationales cite current evidence-based sources and DSM-5-TR
Page 1
, Content covers all major mental health nursing domains
Distractors designed to reflect common student errors
Format mirrors actual HESI exam question style
Content Area Overview:
Content Area Questions Key Topics Weight
Therapeutic Communication & 1-40 active listening, empathy, boundaries, 16%
Nurse-Patient Relationship transference, countertransference
Psychopharmacology 41-80 antidepressants, antipsychotics, mood 16%
stabilizers, anxiolytics, side effects
Crisis Intervention & Suicide 81-110 crisis phases, suicide assessment, safety 12%
Prevention planning, de-escalation
Mood Disorders & Anxiety 111-150 major depression, bipolar disorder, GAD, 16%
panic disorder, PTSD
Psychotic Disorders 151-180 schizophrenia, delusions, hallucinations, 12%
negative symptoms
Personality & Eating Disorders 181-210 borderline, antisocial, anorexia, bulimia, 12%
nursing interventions
Legal & Ethical Issues 211-250 informed consent, confidentiality, 16%
involuntary commitment, HIPAA
Page 2
,Q1. A client with a history of opioid use disorder is admitted for elective surgery. The client has been
maintained on buprenorphine/naloxone for the past 6 months. Which of the following actions by the nurse is
most appropriate regarding the client's buprenorphine/naloxone regimen during the perioperative period?
A. Discontinue buprenorphine/naloxone 72 hours prior to surgery and initiate full agonist opioids for pain
management.
B. Continue buprenorphine/naloxone at the same dose and use non-opioid analgesics and regional anesthesia
for pain control.
C. Increase the dose of buprenorphine/naloxone to compensate for anticipated surgical pain.
D. Switch to methadone for the perioperative period to allow for easier titration of additional opioids.
Correct Answer: B. Continue buprenorphine/naloxone at the same dose and use non-opioid analgesics and
regional anesthesia for pain control.
Rationale: Continuing buprenorphine/naloxone at the same dose is recommended to maintain stability and avoid
withdrawal. Non-opioid analgesics and regional anesthesia are preferred to manage pain without compromising
the buprenorphine's blockade. Discontinuation or dose changes risk relapse and inadequate pain control.
Why Wrong:
A - Discontinuing buprenorphine abruptly can precipitate withdrawal and increase risk of relapse; full
agonists may be less effective due to residual blockade.
C - Increasing buprenorphine dose does not enhance analgesia for acute surgical pain and may lead to
oversedation.
D - Switching to methadone requires careful cross-titration and is not standard perioperative management; it
complicates pain control.
Reference: SAMHSA. (2024). Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use
Disorder and Their Infants. HHS Publication No. (SMA) 24-4930.
Q2. A client with schizophrenia is started on clozapine after failing two previous antipsychotic trials. Which
of the following laboratory parameters requires the most urgent monitoring, and at what frequency is it
initially recommended?
A. Serum creatinine; weekly for the first 6 months.
B. Absolute neutrophil count (ANC); weekly for the first 18 weeks.
C. Liver function tests; monthly for the first year.
D. Electrocardiogram (ECG); at baseline and after each dose increase.
Correct Answer: B. Absolute neutrophil count (ANC); weekly for the first 18 weeks.
Rationale: Clozapine carries a risk of agranulocytosis, necessitating ANC monitoring weekly for the first 18 weeks
of treatment (then every 2 weeks for up to 1 year, then monthly). The other options are not the primary
life-threatening risk associated with clozapine.
Why Wrong:
A - Serum creatinine monitoring is not a required standard for clozapine; renal impairment is not a primary
concern.
C - Liver function tests are not routinely mandated for clozapine; hepatotoxicity is less common than
agranulocytosis.
D - ECG is recommended for some antipsychotics (e.g., ziprasidone) but is not the most urgent lab
monitoring for clozapine.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 16.
Q3. A client receiving electroconvulsive therapy (ECT) for severe major depressive disorder with psychotic
features is being prepared for a treatment session. Which of the following medication adjustments is most
critical to ensure safe and effective ECT?
A. Hold all benzodiazepines for at least 24 hours prior to treatment.
B. Administer a beta-blocker (e.g., esmolol) immediately before the procedure.
Page 3
, C. Discontinue all antidepressants 1 week before ECT initiation.
D. Increase the dose of antipsychotic medication to prevent breakthrough psychosis.
Correct Answer: A. Hold all benzodiazepines for at least 24 hours prior to treatment.
Rationale: Benzodiazepines raise the seizure threshold, reducing the effectiveness of ECT; they are typically held for 24-48
hours before treatment. Beta-blockers are sometimes used to control heart rate but are not mandatory. Antidepressants are
generally continued, and antipsychotics may be continued but not increased.
Why Wrong:
B - Beta-blockers are not a standard requirement; they are used selectively for hemodynamic control.
C - Discontinuing antidepressants is not recommended; they are often continued to maintain therapeutic effect.
D - Increasing antipsychotic dose is not standard; it may increase side effects without clear benefit.
Reference: American Psychiatric Association. (2024). Practice Guideline for the Treatment of Patients With Major Depressive
Disorder, 4th Ed.
Q4. A client with bipolar I disorder is stabilized on lithium carbonate. The client presents to the clinic with a
serum lithium level of 1.8 mEq/L and reports mild tremor, nausea, and blurred vision. Which of the following
interventions is most appropriate?
A. Administer a single dose of furosemide to enhance lithium excretion.
B. Hold the next dose and obtain a repeat serum level in 12 hours.
C. Increase fluid intake to 3-4 L per day and monitor symptoms.
D. Initiate hemodialysis immediately due to the risk of neurotoxicity.
Correct Answer: B. Hold the next dose and obtain a repeat serum level in 12 hours.
Rationale: A lithium level of 1.8 mEq/L is above the therapeutic range (0.6-1.2 mEq/L) and indicates toxicity.
Holding the next dose and rechecking the level is appropriate for mild toxicity. Furosemide can worsen toxicity by
decreasing lithium clearance. Hemodialysis is reserved for severe toxicity (levels >4 mEq/L or with severe
symptoms).
Why Wrong:
A - Furosemide is a loop diuretic that can cause volume depletion and increase lithium reabsorption,
worsening toxicity.
C - Increasing fluid intake may be helpful but is not sufficient; holding the dose is the priority.
D - Hemodialysis is indicated for severe toxicity; this level with mild symptoms does not warrant it.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 15.
Q5. A client with a diagnosis of borderline personality disorder frequently engages in self-harm behaviors,
specifically cutting. During a therapy session, the client states, 'I cut because it's the only way I can feel
something.' Which therapeutic response by the nurse is most consistent with dialectical behavior therapy
(DBT)?
A. I understand you feel that way, but cutting is dangerous. Let's discuss why you need to stop.
B. It sounds like you are experiencing intense emotions. What coping skills from your skills group could you
use instead?
C. You cut because you want attention. We need to find healthier ways to get your needs met.
D. I'm going to ask you to sign a no-harm contract for the next 24 hours.
Correct Answer: B. It sounds like you are experiencing intense emotions. What coping skills from your skills
group could you use instead?
Rationale: DBT emphasizes validation and skill-building. The nurse validates the client's experience and prompts
use of learned coping skills, which is core to DBT. Option A is invalidating; option C is judgmental; option D may
be used but is not the best therapeutic response in this context.
Why Wrong:
A - This response invalidates the client's emotion and focuses on stopping behavior without offering
alternatives.
Page 4
